Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer
Authors
Keywords
-
Journal
Redox Biology
Volume 59, Issue -, Pages 102564
Publisher
Elsevier BV
Online
2022-12-02
DOI
10.1016/j.redox.2022.102564
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2
- (2022) Kerstin Huebner et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Semaphorin 5A suppresses ferroptosis through activation of PI3K-AKT-mTOR signaling in rheumatoid arthritis
- (2022) Qi Cheng et al. Cell Death & Disease
- Current treatment and recent progress in gastric cancer
- (2021) Smita S. Joshi et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Quiescin Sulfhydryl Oxidase 1 Promotes Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Driving EGFR Endosomal Trafficking and Inhibiting NRF2 Activation
- (2021) Jialei Sun et al. Redox Biology
- GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis
- (2021) Qiujie Wang et al. Cell Death & Disease
- Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response‑induced upregulation of CHAC1 expression
- (2021) Zhiwei Wang et al. ONCOLOGY REPORTS
- Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines
- (2021) Jiashuo Zheng et al. Cell Death & Disease
- Long Noncoding RNA RP11-357H14.17 Plays an Oncogene Role in Gastric Cancer by Activating ATF2 Signaling and Enhancing Treg Cells
- (2021) Tang Xiaoli et al. Biomed Research International
- The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression
- (2020) Guang Lei et al. CELL RESEARCH
- MicroRNA-216a-3p promotes sorafenib sensitivity in hepatocellular carcinoma by downregulating MAPK14 expression
- (2020) Zhong Wan et al. Aging-US
- ATF2 inhibits ani-tumor effects of BET inhibitor in a negative feedback manner by attenuating ferroptosis
- (2020) Lina Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pterostilbene enhances sorafenib’s anticancer effects on gastric adenocarcinoma
- (2020) Tingting Zhao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Chaperone-mediated autophagy is involved in the execution of ferroptosis
- (2019) Zheming Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
- (2019) Weimin Wang et al. NATURE
- Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
- (2019) F Wang et al. ANNALS OF ONCOLOGY
- ATF3 promotes erastin-induced ferroptosis by suppressing system Xc–
- (2019) Liyuan Wang et al. CELL DEATH AND DIFFERENTIATION
- Intercellular interaction dictates cancer cell ferroptosis via NF2–YAP signalling
- (2019) Jiao Wu et al. NATURE
- A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis
- (2019) Yilong Zou et al. Nature Communications
- The activating transcription factor 2: an influencer of cancer progression
- (2019) Kerstin Huebner et al. MUTAGENESIS
- microRNA arm-imbalance in part from complementary targets mediated decay promotes gastric cancer progression
- (2019) Zhengyi Zhang et al. Nature Communications
- HSP110 sustains chronic NF-κB signaling in activated B cell diffuse large B cell lymphoma through MyD88 stabilization
- (2018) Christophe Boudesco et al. BLOOD
- ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling
- (2018) Satoshi Inoue et al. Endocrine Connections
- Ferroptosis: bug or feature?
- (2017) Scott J. Dixon IMMUNOLOGICAL REVIEWS
- Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
- (2017) Vasanthi S. Viswanathan et al. NATURE
- A Novel Pak1/ATF2/miR-132 Signaling Axis Is Involved in the Hematogenous Metastasis of Gastric Cancer Cells
- (2017) Funan Liu et al. Molecular Therapy-Nucleic Acids
- Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis
- (2016) Xiaofang Sun et al. HEPATOLOGY
- ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma
- (2016) Deng-shuang Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- HSP105 Recruits Protein Phosphatase 2A To Dephosphorylate β-Catenin
- (2015) Nancy Yu et al. MOLECULAR AND CELLULAR BIOLOGY
- Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy
- (2015) E Lau et al. ONCOGENE
- HSPB1 as a novel regulator of ferroptotic cancer cell death
- (2015) X Sun et al. ONCOGENE
- The transcription factor ATF2 promotes melanoma metastasis by suppressing protein fucosylation
- (2015) Eric Lau et al. Science Signaling
- The transcription factor ATF2 promotes melanoma metastasis by suppressing protein fucosylation
- (2015) Eric Lau et al. Science Signaling
- Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer
- (2014) Ruochuan Sun et al. Molecular Cancer
- In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
- (2014) Ramona Rudalska et al. NATURE MEDICINE
- Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
- (2014) Scott J Dixon et al. eLife
- Cell death and diseases related to oxidative stress:4-hydroxynonenal (HNE) in the balance
- (2013) S Dalleau et al. CELL DEATH AND DIFFERENTIATION
- A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer
- (2013) Yasuhide Yamada et al. Gastric Cancer
- PKCε Promotes Oncogenic Functions of ATF2 in the Nucleus while Blocking Its Apoptotic Function at Mitochondria
- (2012) Eric Lau et al. CELL
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis
- (2011) Coralie Dorard et al. NATURE MEDICINE
- Phase II Study of Sorafenib in Combination With Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: ECOG 5203
- (2010) Weijing Sun et al. JOURNAL OF CLINICAL ONCOLOGY
- Helicobacter pylori enhances cyclooxygenase 2 expression via p38MAPK/ATF-2 signaling pathway in MKN45 cells
- (2009) Qi Li et al. CANCER LETTERS
- Suppressor role of activating transcription factor 2 (ATF2) in skin cancer
- (2008) A. Bhoumik et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search